Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Softline launched production of payment terminals

12/12/24 SOFL

Elena Bekhtina continues to build up her stake in Delimobil

12/12/24 DELI

M.Video-Eldorado interested customers in subscription M.Combo

12/12/24 MVID

Shareholders of SFI approved dividends

12/11/24 SFIN

Fesco launched container transportation between Kenya and Novorossiysk

12/11/24 FESH

Ultimate Education has raised over ₽550 million in Pre-IPO funding

12/11/24 OTCI

Inter RAO bought a part of the Moscow Silk business quarter

12/11/24 IRAO

Winlab has entered the marketplaces

12/11/24 BELU

Aeroflot's passenger traffic in November increased by 11%

12/11/24 AFLT

Yamal LNG added to the tanker fleet for LNG transshipment in Murmansk

12/11/24 NVTK